Share price action suggests someone wants the sp down.
I wonder why.
Printable View
Share price action suggests someone wants the sp down.
I wonder why.
Oh Balance, I have seen it so many times where timings of events just seem rather coincidental. Not saying this is the case here .... but get cynical all the same
BTW .... I know nothing technical in this game ...but Mr W's seems to have had a relevantly experienced career
.....MR WILLIAMS APPEARS TO HAVE THE GOODS ALSO. DARLING & CO. DOING VERY WELL IN ASSEMBLING A HIGH QUALITY DIRECTORSHIP WITH ALL THE RIGHT CREDENTIALS. CAN'T IMAGINE ANY OF THEM SIGNING UP WITHOUT FULLY RESEARCHING THE UPSIDE TO PEB's TECHNOLOGY AND BUSINESS PLAN.......THEIR OWN CREDIBILITY IS ALSO AT STAKE. THE POSITIVES JUST KEEP BUILDING FOR PEB. GOOD WORK!
Hi Balance,
I often read your posts and respect the level of research and information that you present... but the top 100 have purchased a minimal 171k of shares over the last two weeks which only represents a 0.08% movement... hardly smart money buying up.
Long time lurker, first time poster
I have found the information on these boards useful and fun to read. I thought I would add my ten cents as to why I hold PEB.
First and foremost they have an exciting market which they are trying to crack and no doubt they will earn staggering amounts of cash if successful in the US.
I have modelled PEB and can come up with a share price in the vicinity of $10 +. My main method for valuation was a DCF, constructed by looking at the way other successful cancer diagnostics have captured their respective markets and the rate at which this happens. Obviously this is a best case valuation and could be party to a number of risks which I have clearly ignored in a best case scenario.
Genomics have a breast cancer screening diagnostic which took well over 10 years to gain around 70% of their possible market. It is slow going but if PEB starts well I would expect the market to price in this expectation rather quickly, as did Genomics shareholders.
The second company which intrigues me is Exact Sciences. They are in the process of regulatory approval, and comemrcialisation of a non invasive colon cancer diagnostic should begin soon. They are valued at 1bn NZD + and have about 10 analysts covering the stock. The pricing of Blue Sky in America amazes me and I hope the same fate eventuates for PEB.
I would be really eager to know the number of trials that are going on with DHB's around NZ as well. Clearly the uptake by these organisations should be a clear sign as to whats to come in America. If any body knows anything more about that, I would be keen to know!
Any way, lets all enjoy the ride, to riches or ashes!